Q1WB
GILD icon

Quest 10 Wealth Builders’s Gilead Sciences GILD Stock Holding History

Quest 10 Wealth Builders’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Sell
97
-11
-10% -$1.45K 0.01% 415
2026
Q1 		$15K Sell
108
-4
-4% -$560 0.01% 391
2025
Q4 		$13.7K Sell
112
-22
-16% -$2.67K 0.01% 370
2025
Q3 		$14.9K Buy
134
+17
+15% +$1.93K 0.01% 326
2025
Q2 		$13K Sell
117
-6
-5% -$639 0.01% 361
2025
Q1 		$13.8K Sell
123
-24
-16% -$2.48K 0.01% 324
2024
Q4 		$13.6K Buy
+147
New +$13.2K 0.01% 353

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quest 10 Wealth Builders's GILD Position: Q2 2026 in Review

Quest 10 Wealth Builders reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $1.45K and leaving 97 shares worth $12.2K. The position accounts for 0.01% of the portfolio, ranked #415.

Quest 10 Wealth Builders first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $15K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quest 10 Wealth Builders held 97 shares of Gilead Sciences worth $12.2K as of Q2 2026.
  • Quest 10 Wealth Builders sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up 0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #415 holding.
  • Quest 10 Wealth Builders first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Quest 10 Wealth Builders's Gilead Sciences position peaked at $15K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.